Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40762119	s-rnp70ab	— (—)	3083	3494	100.00%	Distribution not available
40762119	s-rnp70	— (—)	243	288	100.00%	Distribution not available
40762119	s-rnp70ab	u/ml (u/ml)	36	50	0.00%
40762119	s-rnp70	u/ml (u/ml)	5	6	0.00%		Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Autoimmune diseases excluding thyroid diseases

1135

1582

4.03

323.31

1.2

1.1

73.26

23.86

u/ml

—

Autoimmune diseases excluding thyroid diseases, strict definition

1100

1539

4.03

314.12

1.2

1.1

73.26

23.86

u/ml

—

Other systemic involvement of connective tissue

611

691

9.24

307.65

1.3

1.1

83.46

12.24

u/ml

—

Systemic connective tissue disorders

819

864

9.92

307.65

1.3

1.1

80.37

12.24

u/ml

—

ILD medications: immunosuppressive drugs

808

1562

5.05

307.65

1.2

1.1

83.59

33.20

u/ml

2.17

Reimbursement for rheumatic diseases

762

1726

4.49

305.40

1.2

1.1

75.96

49.58

u/ml

—

Finngen Rheumatological endpoints

1038

1487

4.03

298.99

1.2

1.1

71.56

25.37

u/ml

—

Autoimmune diseases related-to ILD

923

2209

3.72

278.09

1.3

1.1

74.58

57.80

u/ml

0.32

ILD medications

1155

1805

3.55

277.70

1.2

1.1

78.46

34.63

u/ml

2.17

ILD medications: prednisolone, methylprednisolone, prednisone

1058

1771

3.41

243.05

1.2

1.1

67.62

32.93

u/ml

1.46

L04AX Other immunosuppressants

676

1688

4.08

239.08

1.2

1.1

82.71

53.32

u/ml

0.87

Second line medication for Crohn's disease

683

1736

4.00

235.68

1.2

1.1

82.71

49.94

u/ml

1.05

Polyarthropathies

707

1205

3.96

211.89

1.2

1.1

48.50

76.94

u/ml

0.72

Other specific joint derangements/joint disorders

748

1390

3.65

201.38

1.1

20.43

81.16

u/ml

—

Pain in joint

650

1087

4.01

197.59

1.1

24.80

83.05

u/ml

—

Inflammatory bowel disease treatment related agents

1067

2072

2.95

196.20

1.2

1.1

71.06

55.30

u/ml

0.46

Autoimmune diseases

968

1599

3.12

187.47

1.2

1.1

65.87

23.86

u/ml

—

Oral corticosteroids

974

2000

2.97

185.21

1.2

1.1

65.80

56.64

u/ml

0.21

First line medication for Crohn's disease

1007

1878

2.95

182.56

1.2

1.1

69.05

59.45

u/ml

0.22

Used for control exclusion in common control thyroid runs

904

1471

3.14

176.74

1.2

1.1

67.59

23.86

u/ml

—

Rheumatoid arthritis

347

667

4.81

147.51

1.2

1.1

60.50

58.20

u/ml

—

Other specified/unspecified arthritis

301

595

5.15

143.07

1.2

1.1

70.50

67.65

u/ml

—

Examination and observation for other reasons

576

1076

3.29

129.09

1.1

53.71

81.92

u/ml

—

Other soft tissue disorders, not elsewhere classified

762

1820

2.61

115.31

1.2

1.1

54.83

77.97

u/ml

—

Rheumatoid arthritis, including avohilmo

392

1137

3.50

111.85

1.2

1.1

75.33

54.92

u/ml

—

Arthropathies

731

1430

2.62

105.27

1.1

41.88

80.77

u/ml

—

Pain in limb

633

1752

2.63

102.24

1.2

1.1

71.17

73.87

u/ml

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

761

2358

2.33

94.85

1.2

1.1

70.90

58.47

u/ml

—

Other joint disorders

676

1422

2.55

93.84

1.2

1.1

16.20

80.77

u/ml

—

General symptoms and signs

831

1892

2.21

83.80

1.2

1.1

53.40

62.45

u/ml

—

Dermatitis and eczema

817

2510

2.15

82.29

1.2

1.1

86.82

52.94

u/ml

0.78

Fever of other and unknown origin

420

1423

2.76

79.04

1.2

1.1

96.67

50.82

u/ml

—

Azathioprine

172

367

4.78

75.03

1.3

1.1

45.33

50.15

u/ml

—

Diseases of the skin and subcutaneous tissue

736

1671

2.22

74.93

1.2

1.1

60.13

53.36

u/ml

—

Headache

503

1739

2.44

71.89

1.2

1.1

38.02

57.33

u/ml

—

Medical observation and evaluation for suspected diseases and conditions

518

1079

2.47

67.21

1.2

1.1

29.00

81.92

u/ml

—

Seropositive rheumatoid arthritis, wide

255

804

3.22

63.94

1.2

1.1

71.20

34.87

u/ml

—

Other disorders of lacrimal gland

295

1026

2.91

62.29

1.2

1.1

78.00

29.69

u/ml

—

Other/unspecified seropositive rheumatoid arthritis

250

794

3.19

61.95

1.2

1.1

71.20

34.87

u/ml

—

Tramadol

569

1662

2.21

61.75

1.2

1.1

58.24

59.47

u/ml

—

Asthma, excluding more controls

564

1332

2.27

61.65

1.1

48.02

57.71

u/ml

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

248

790

3.19

61.16

1.2

1.1

71.20

34.87

u/ml

—

Asthma

574

1385

2.24

60.71

1.1

48.02

57.71

u/ml

—

Asthma (mode)

563

1394

2.23

59.66

1.1

48.02

57.71

u/ml

—

L04AA Selective immunosuppressants

222

675

3.34

59.18

1.3

1.1

49.50

36.03

u/ml

—

Disorders of lacrimal system

335

1292

2.62

57.95

1.2

1.1

78.00

28.32

u/ml

—

Cardiovascular diseases

498

1186

2.30

56.58

1.1

58.68

77.57

u/ml

0.39

Soft tissue disorders

707

1850

1.99

55.70

1.2

1.1

40.71

77.97

u/ml

—

Abnormalities of breathing

632

1868

2.02

53.46

1.2

1.1

53.27

64.49

u/ml

0.27

Codeine

666

1863

1.97

51.83

1.2

1.1

19.03

72.40

u/ml

—

Pain in throat and chest

587

1763

2.05

51.70

1.2

1.1

83.20

64.28

u/ml

—

Disorders of eyelid, lacrimal system and orbit

570

2226

2.02

51.28

1.2

1.1

70.33

51.66

u/ml

—

Asthma, unspecified (mode), excluding more controls

363

1199

2.39

49.54

1.2

1.1

41.40

47.00

u/ml

—

Asthma, unspecified (mode)

367

1240

2.36

48.75

1.1

41.40

47.00

u/ml

—

Any reimbursement code in KELA

452

1007

2.26

48.29

1.1

72.02

32.86

u/ml

—

Codeine or tramadol medication

762

2312

1.83

47.83

1.2

1.1

19.03

63.43

u/ml

—

Asthma (only as main-diagnosis), excluding more controls

477

1332

2.14

47.20

1.1

49.17

57.71

u/ml

—

Diseases of oesophagus, stomach and duodenum

702

2304

1.86

47.06

1.2

1.1

85.29

59.26

u/ml

—

Asthma (only as main-diagnosis)

482

1385

2.11

45.99

1.1

49.17

57.71

u/ml

—

Any gastric operation

584

1476

1.99

45.74

1.1

45.14

73.05

u/ml

—

GASTRO-related operations

584

1476

1.99

45.74

1.1

45.14

73.05

u/ml

—

Hypothyroidism, strict autoimmune

423

1291

2.18

44.83

1.2

1.1

60.71

23.86

u/ml

—

Disorders of conjunctiva

572

2528

1.90

44.11

1.1

71.75

59.69

u/ml

—

Abnormal findings on diagnostic imaging of lung

296

1192

2.44

44.04

1.1

66.60

34.47

u/ml

—

Symptoms and signs involving the circulatory and respiratory systems

690

1877

1.85

43.55

1.2

1.1

56.50

64.49

u/ml

—

Dorsalgia

656

1916

1.86

43.07

1.1

66.33

79.27

u/ml

—

Conjunctivitis

527

2409

1.92

41.77

1.1

78.43

61.74

u/ml

—

Nerve, nerve root and plexus disorders

670

2356

1.79

40.52

1.2

1.1

76.83

56.89

u/ml

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

390

1737

2.09

40.05

1.1

52.38

46.20

u/ml

—

Asthma (diagnoses ohter than nonallergic)

569

2650

1.85

40.01

1.1

35.40

65.34

u/ml

—

Other dorsopathies, not elsewhere classified

661

1927

1.82

40.00

1.1

43.53

79.27

u/ml

—

Asthma, including avohilmo

752

2573

1.70

37.55

1.1

48.02

68.97

u/ml

—

Dyspnoea

557

2359

1.82

36.61

1.2

1.1

82.63

50.05

u/ml

—

Opioids

640

1891

1.78

36.52

1.1

36.31

71.73

u/ml

—

Oedema, not elsewhere classified

199

743

2.69

36.51

1.2

1.1

—

42.13

—

Neurological diseases

591

1634

1.83

36.12

1.1

57.60

66.88

u/ml

—

Neurotic, stress-related and somatoform disorders

599

2418

1.77

35.55

1.2

1.1

65.56

66.07

u/ml

—

Dorsopathies

665

1948

1.75

35.29

1.1

9.03

79.27

u/ml

—

Gastro-oesophageal reflux disease

424

1943

1.94

35.24

1.2

1.1

55.00

55.59

u/ml

—

Persons encountering health services for specific procedures and health care

691

2517

1.71

35.22

1.1

72.00

56.81

u/ml

—

Anxiety (asthma-related co-morbidities)

427

1735

1.95

35.14

1.1

1.2

90.60

65.92

u/ml

—

Anxiety disorders

602

2440

1.76

34.86

1.2

1.1

65.56

66.07

u/ml

—

Depression

628

2501

1.74

34.74

1.1

73.88

63.68

u/ml

—

Anxiety disorders, excluding more controls

557

2071

1.79

34.02

1.2

1.1

77.43

67.08

u/ml

—

All anxiety disorders

432

1822

1.92

34.01

1.1

90.60

69.72

u/ml

—

Other bacterial diseases

568

2228

1.77

33.64

1.2

1.1

93.40

52.09

u/ml

—

Cardiovascular diseases (excluding rheumatic etc)

468

1428

1.90

33.43

1.1

53.72

73.56

u/ml

—

Other intervertebral disc disorders

508

1696

1.84

33.36

1.2

1.1

24.53

84.16

u/ml

—

Mood [affective] disorders

656

2556

1.69

33.03

1.1

73.14

61.73

u/ml

—

Mood disorders

656

2561

1.69

32.62

1.1

73.14

61.73

u/ml

—

Urticaria and erythema

269

1253

2.16

30.62

1.2

1.1

97.71

50.38

u/ml

—

Atopic dermatitis

375

1670

1.93

30.27

1.1

104.20

48.30

u/ml

—

Antihypertensive medication - note that there are other indications

444

1300

1.88

30.18

1.1

69.56

61.64

u/ml

—

Chronic lower respiratory diseases

750

2529

1.61

29.77

1.2

1.1

50.63

66.33

u/ml

0.42

Shoulder lesions

434

1448

1.84

28.69

1.1

44.67

67.02

u/ml

—

Gastrointestinal diseases

402

1068

1.89

27.51

1.1

60.80

59.94

u/ml

—

Gingivitis and periodontal diseases

521

1558

1.73

27.05

1.1

56.04

72.19

u/ml

—

Visual disturbances

293

1487

1.98

26.52

1.2

1.1

69.83

44.58

u/ml

—

Episodal and paroxysmal disorders

688

2214

1.60

26.28

1.1

60.27

71.31

u/ml

—

Diseases of the eye and adnexa

527

1548

1.71

26.02

1.1

62.17

74.94

u/ml

—

Visual disturbances and blindness

306

1591

1.93

25.81

1.2

1.1

69.83

48.51

u/ml

—

Other diseases of intestines

647

2354

1.60

25.78

1.2

1.1

79.00

63.86

u/ml

—

Care involving use of rehabilitation procedures

387

2058

1.79

25.55

1.1

1.2

78.83

46.10

u/ml

—

Psoriasis vulgaris

137

514

2.69

25.43

1.1

—

29.87

—

Diseases of oral cavity, salivary glands and jaws

518

1564

1.70

25.41

1.2

1.1

41.64

72.19

u/ml

—

Cystitis

544

2014

1.66

25.02

1.1

58.24

60.76

u/ml

—

Asthma, hospital admissions , main diagnosis only

501

2709

1.66

24.98

1.1

49.17

61.00

u/ml

—

Dermatopolymyositis

9.57

24.95

1.6

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

541

2055

1.66

24.91

1.2

1.1

60.83

63.15

u/ml

—

541

2055

1.66

24.91

1.2

1.1

60.83

63.15

u/ml

—

Other heart diseases

317

1095

1.92

24.31

1.1

61.00

81.50

u/ml

—

Metabolic disorders

545

2072

1.64

24.16

1.2

1.1

54.50

56.01

u/ml

—

Hypertensive diseases (excluding secondary)

345

1080

1.87

23.52

1.2

1.1

50.04

77.50

u/ml

—

Respiratory disorders in diseases classified elsewhere

8.83

23.37

1.9

1.1

—

Hypertension, essential

474

1605

1.69

23.23

1.2

1.1

43.03

71.71

u/ml

—

Disorders of sclera, cornea, iris and ciliary body

320

1748

1.84

23.22

1.2

1.1

106.83

44.58

u/ml

—

Tumor necrosis factor alpha inhibitors

118

432

2.76

23.05

1.3

1.1

—

36.03

—

Other diseases of upper respiratory tract

646

2159

1.56

22.83

1.1

61.31

56.81

u/ml

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

658

2428

1.55

22.73

1.1

76.86

55.97

u/ml

—

Aplastic and other anaemias

230

1093

2.01

21.48

1.1

55.20

34.62

u/ml

—

Viral hepatitis, IBD co-morbidity

6.28

21.46

1.1

—

Influenza and pneumonia

617

2648

1.54

21.16

1.2

1.1

65.88

61.01

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

300

1030

1.86

20.63

1.2

1.1

42.80

67.22

u/ml

—

Any operation in hilmo

9.70

20.11

1.1

—

Other gastritis (incl. Duodenitis)

133

553

2.42

20.03

1.2

1.1

—

27.24

—

Endocrine, nutritional and metabolic diseases

506

1609

1.61

19.87

1.1

32.37

69.44

u/ml

—

Other heart diseases, wide

553

2214

1.55

19.78

1.1

61.00

63.62

u/ml

—

Parasetamol

483

1525

1.62

19.78

1.1

55.70

67.91

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

572

2599

1.53

19.43

1.2

1.1

74.29

58.39

u/ml

—

Complications of surgical and medical care, not elsewhere classified

546

2548

1.54

19.36

1.1

65.90

56.05

u/ml

—

Hypertensive diseases

469

1652

1.61

19.22

1.2

1.1

50.04

70.11

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

533

2242

1.55

19.18

1.2

1.1

47.88

51.84

u/ml

—

COPD/asthma/ILD related infections

622

2057

1.52

19.17

1.2

1.1

49.90

66.33

u/ml

—

COPD/asthma related infections

622

2057

1.52

19.17

1.2

1.1

49.90

66.33

u/ml

—

All pneumoniae

575

2615

1.52

19.11

1.2

1.1

74.29

57.44

u/ml

—

Drug-induced systemic lupus erythematosus

10.43

19.07

1.6

1.1

—

Hypertension

467

1650

1.61

18.89

1.2

1.1

50.04

70.11

u/ml

—

Internal derangement of knee

186

910

2.05

18.68

1.2

1.1

—

76.94

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

486

2101

1.57

18.58

1.1

1.2

64.37

62.62

u/ml

—

Triptan medication for migraine, single purchase ok

486

2101

1.57

18.58

1.1

1.2

64.37

62.62

u/ml

—

Heart failure, not strict

396

1666

1.64

18.31

1.2

1.1

71.38

39.16

u/ml

—

Urticaria

201

1023

1.98

18.27

1.1

104.80

50.38

u/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

552

2564

1.52

18.17

1.2

1.1

74.29

55.49

u/ml

—

Other disorders of veins

234

1264

1.86

17.73

1.1

45.83

36.89

u/ml

—

Other enthesopathies

172

839

2.06

17.61

1.1

—

49.24

—

Pneumonia, organism unspecified

495

2333

1.54

17.53

1.2

1.1

90.60

57.83

u/ml

—

647

2330

1.47

17.35

1.1

63.24

63.62

u/ml

—

Hypothyroidism, other/unspecified

509

2207

1.53

17.12

1.1

65.13

56.33

u/ml

—

Other dermatomyositis

16.30

16.95

1.1

—

Asthma/COPD (KELA code 203)

535

2517

1.50

16.88

1.1

52.70

66.33

u/ml

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

527

2313

1.51

16.74

1.1

65.13

59.30

u/ml

—

Persons encountering health services in other circumstances, wide

677

2433

1.45

16.72

1.1

86.80

55.97

u/ml

—

Spinal stenosis

247

1073

1.81

16.57

1.2

1.1

—

51.13

—

Disorders of the thyroid gland

531

2317

1.50

16.53

1.2

1.1

58.37

56.28

u/ml

—

Purpura and other haemorrhagic conditions

339

2.62

15.71

1.3

1.1

—

33.64

—

Voice disturbances

165

831

2.00

15.56

1.1

—

28.02

—

Other special examinations and investigations of persons without complaint or reported diagnosis

351

1079

1.65

15.55

1.2

1.1

78.84

81.92

u/ml

—

Dental caries 2

452

2340

1.52

15.52

1.2

1.1

68.17

57.54

u/ml

—

Complications of procedures, not elsewhere classified

432

2448

1.53

15.39

1.1

77.14

51.30

u/ml

—

Abnormalities of heart beat

184

970

1.89

14.74

1.2

1.1

101.40

63.48

u/ml

—

Acute upper respiratory infections

574

2505

1.44

14.38

1.1

69.17

59.37

u/ml

—

Any mental disorder

624

2193

1.43

14.35

1.1

58.67

64.72

u/ml

—

Dentofacial anomalies [including malocclusion]

163

834

1.94

14.23

1.2

1.1

48.60

69.11

u/ml

—

Other diseases of urinary system

572

2237

1.44

14.21

1.1

34.60

61.00

u/ml

—

Psychiatric diseases

614

2163

1.42

13.96

1.1

58.67

64.72

u/ml

—

Dental caries 2 and operation codes

437

2327

1.50

13.92

1.2

1.1

49.80

60.85

u/ml

—

Acute upper respiratory infections of multiple and unspecified sites

411

2037

1.52

13.82

1.1

94.60

66.00

u/ml

—

386

2.40

13.77

1.2

1.1

—

50.15

—

Recurring oral aphthae, including avohilmo

394

2.38

13.64

1.1

—

29.87

—

Other septicaemia

167

871

1.89

13.44

1.2

1.1

—

31.90

—

Other and unspecified urticaria

127

618

2.07

13.26

1.2

1.1

104.80

36.03

u/ml

—

Bronchitis

578

2689

1.41

13.26

1.2

1.1

70.63

60.07

u/ml

—

Hypoplasia of dental enamel, including avohilmo

7.31

11.99

1.1

1.5

—

Molar incisor enamel hypoplasia, with caries

7.80

11.92

1.1

1.5

—

Polycystic ovarian syndrome, consortium definition

449

1868

1.45

11.92

1.2

1.1

71.60

61.78

u/ml

—

Benign neoplasms

531

2102

1.41

11.92

1.2

1.1

63.60

68.61

u/ml

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

465

2211

1.44

11.90

1.1

60.71

58.97

u/ml

—

Pain and other conditions associated with female genital organs and menstrual cycle

137

684

1.93

11.79

1.2

1.1

—

53.37

—

Certolizumab pegol

5.52

11.42

1.2

—

Nephrotic syndrome

4.51

11.23

1.2

1.1

—

ILD and respiratory illness in diseases classified elsewhere

11.66

11.18

1.3

1.2

—

Kela reimbursement Agammaglobulinemia (D80-84)

7.63

11.09

1.2

1.1

—

Selective serotonin reuptake inhibitors

531

2018

1.39

10.68

1.1

61.57

66.41

u/ml

—

Speech and linguistic disorders, excluding more controls

177

2.79

10.51

1.1

1.2

—

92.64

—

Benign neoplasms

432

1718

1.43

10.30

1.2

1.1

63.60

70.63

u/ml

—

Nonorganic sleeping disorders, excluding more controls

106

532

2.00

10.28

1.1

—

69.17

—

Pulmonary eosinophilia, not elsewhere classified

6.89

10.25

1.0

1.1

—

Dental caries 2, only avohilmo

419

2338

1.42

10.22

1.2

1.1

68.17

60.49

u/ml

—

Fibroblastic disorders

104

521

2.01

10.13

1.2

1.1

—

32.64

—

Chronic diseases of tonsils and adenoids

433

1945

1.41

10.02

1.1

48.20

58.96

u/ml

—

Spondyloarthritis

437

2.09

9.95

1.2

1.1

—

34.87

—

Intestinal infectious diseases

484

2747

1.37

9.86

1.2

1.1

121.67

54.55

u/ml

—

Postviral fatigue syndrome

7.13

9.82

1.1

1.3

—

Temporomandibular joint disorders, including avohilmo

248

1605

1.55

9.78

1.3

1.1

62.67

60.22

u/ml

—

Hyperkinetic disorders, excluding more controls

257

2.40

9.53

1.1

1.2

—

89.37

—

Lyme disease

136

765

1.79

9.34

1.1

—

31.90

—

Neoplasms

428

1642

1.40

9.18

1.1

68.14

68.23

u/ml

—

Unspecified privation

279

2.31

8.95

1.1

—

27.24

—

Polymyositis

8.30

8.92

2.3

1.1

—

Disorders of parathyroid gland

104

539

1.92

8.90

1.2

1.1

—

32.37

—

Personality disorders, excluding more controls

141

816

1.74

8.80

1.1

58.40

62.02

u/ml

—

Dermatopolymyositis, unspecified

10.53

8.72

1.6

1.1

—

Hernia of abdominal wall, postoperative

398

2.05

8.41

1.2

1.1

—

35.53

—

Crystal arthropathies, rheuma endpoint

5.88

8.36

1.1

1.0

—

Other disorders of the musculoskeletal system and connective tissue

393

2.05

8.33

1.2

1.1

—

27.24

—

Thrombotic microangiopathy

15.27

8.31

2.3

1.2

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

6.37

8.26

1.7

1.2

—

Nausea and vomiting

129

735

1.73

8.04

1.2

1.1

—

64.27

—

Other specified/unspecified necrotizing vasculopathies

5.98

7.89

1.3

1.1

—

Diseases of the ear and mastoid process

626

2462

1.29

7.76

1.1

29.03

70.06

u/ml

—

Diseases of the digestive system

198

1286

1.54

7.76

1.3

1.1

—

44.85

—

Superficial injury of head

113

639

1.78

7.70

1.1

—

29.87

—

Chronic laryngitis and laryngotracheitis

371

2.03

7.70

1.1

—

41.60

—

Deviated nasal septum

142

856

1.66

7.66

1.2

1.1

—

47.67

—

Other/unspecified crystal arthropathies

8.71

7.64

1.1

—

Dermatographic urticaria

187

2.49

7.58

1.0

1.1

—

33.84

—

Ehlers-Danlos syndrome

5.35

7.51

1.2

—

Genitourinary diseases

295

1027

1.44

7.49

1.2

1.1

34.87

76.00

u/ml

—

Other abnormalities of plasma proteins

5.30

7.49

1.3

1.1

—

Congenital malformation of biliary tract

17.57

7.43

1.1

1.0

—

Lumbosacral root disorders, not elsewhere classified

5.14

7.23

1.0

1.1

—

Wegener granulomatosis

5.11

7.22

1.9

1.1

—

Nonorganic sleeping disorders

106

602

1.77

7.17

1.1

—

59.02

—

Phobic anxiety disorders

395

1.96

7.16

1.1

—

79.03

—

Fall on same level

603

2642

1.28

7.14

1.1

53.67

66.21

u/ml

—

Injuries to the knee and lower leg

605

2724

1.27

7.04

1.2

1.1

33.22

73.13

u/ml

—

Speech and linguistic disorders

249

2.17

6.82

1.1

1.2

—

46.84

—

Insomnia

502

1.80

6.52

1.2

1.1

—

50.15

—

Convulsions, not elsewhere classified

547

1.76

6.46

1.1

—

55.56

—

Sleep disorders

113

676

1.68

6.39

1.2

1.1

—

59.02

—

Viral warts

281

2.08

6.38

1.3

1.1

—

29.87

—

Other skin changes

419

1.87

6.38

1.2

1.1

—

29.87

—

Non-allergic asthma (mode), excluding more controls

482

1.79

6.24

1.2

1.1

—

46.83

—

Localized swelling, mass and lump of skin and subcutaneous tissue

141

898

1.58

6.21

1.2

1.1

—

44.91

—

Non-allergic asthma (mode)

483

1.79

6.20

1.2

1.1

—

46.83

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.22

6.14

1.2

1.1

—

Pacemaker

112

658

1.66

6.07

1.1

—

36.60

—

Cerebral palsy and other paralytic syndromes

302

2.00

5.97

1.3

1.1

—

29.87

—

Other Crohn's disease

190

2.28

5.97

1.2

1.1

—

27.24

—

Concussion

222

1350

1.43

5.95

1.2

1.1

—

60.16

—

Personality disorders

141

914

1.55

5.78

1.1

58.40

50.75

u/ml

—

Acute pharyngitis

445

1.79

5.75

1.1

—

71.00

—

Other obstetric conditions, not elsewhere classified

196

873

1.46

5.75

1.2

1.1

102.00

55.61

u/ml

—

Primary gonarthrosis, bilateral

215

1326

1.42

5.69

1.1

—

32.86

—

Congenital malformations and deformations of the musculoskeletal system

272

2.03

5.68

1.1

—

40.37

—

Hyperkinetic disorders

325

1.92

5.64

1.1

1.2

—

65.17

—

Noninflammatory disorders of female genital tract

248

892

1.40

5.53

1.2

1.1

76.50

73.47

u/ml

—

Acute myeloid leukaemia and myelodysplastic syndromes

4.55

5.53

1.2

1.1

—

Hyperparathyroidism

471

1.75

5.50

1.2

1.1

—

38.60

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

190

849

1.46

5.48

1.2

1.1

102.00

59.30

u/ml

—

Coeliac disease

376

1.85

5.46

1.5

1.1

—

29.87

—

Superficial injury of wrist and hand

105

645

1.64

5.44

1.1

—

68.42

—

Disturbance of activity and attention

304

1.93

5.32

1.1

1.2

—

82.74

—

Falls/tendency to fall

579

2346

1.24

5.29

1.1

54.80

68.88

u/ml

—

Disorders of choroid and retina

339

1888

1.31

5.24

1.2

1.1

44.52

52.29

u/ml

—

Injuries to unspecified part of trunk, limb or body region

250

2.01

5.12

1.1

—

33.64

—

Abnormal involuntary movements

342

1.85

5.07

1.2

1.1

—

29.87

—

Scleritis

3.98

5.02

1.1

—

Disorders of psychological development

317

1.85

5.01

1.1

1.2

—

64.65

—

Sequelae with surgical and medical care as external cause

537

1.66

4.98

1.2

1.1

—

27.24

—

Acne

288

1.92

4.94

1.1

—

72.87

—

Other nonthrombocytopenic purpura

5.14

4.81

1.2

1.1

—

Intracranial trauma

253

1412

1.34

4.69

1.2

1.1

—

65.14

—

Other keratitis

302

1.86

4.64

1.1

—

27.24

—

8.60

4.63

1.2

—

Haemolytic-uraemic syndrome

10.82

4.62

1.3

—

Schizophrenia

483

0.37

4.60

1.2

1.1

—

27.24

—

Pyoderma gangrenosum

4.92

4.57

1.4

1.2

—

Diseases of middle ear and mastoid

277

1731

1.31

4.51

1.1

52.89

76.64

u/ml

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

578

0.43

4.51

1.2

1.1

—

36.80

—

Fracture of lumbar spine and pelvis

513

1.64

4.50

1.2

1.1

—

27.24

—

Polymorphous light eruption

4.68

4.34

1.3

1.0

—

Monoamine oxidase A inhibitors

331

1.79

4.33

1.2

1.1

—

19.84

—

Personal history of other diseases and conditions

383

1.72

4.26

1.1

—

58.02

—

Social phobias

213

1.98

4.20

1.1

—

80.24

—

Paralytic ileus and intestinal obstruction

626

1.55

4.18

1.2

1.1

—

37.46

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

135

934

1.45

4.17

1.1

—

54.32

—

Hypopituitarism

167

2.11

4.13

1.2

—

46.24

—

139

911

1.44

4.10

1.1

—

32.33

—

Sequelae of cerebrovascular disease

119

705

1.48

4.09

1.2

1.1

—

32.33

—

Disorders of adult personality and behaviour

139

971

1.44

4.09

1.1

58.40

51.10

u/ml

—

Myelodysplastic syndrome

8.18

4.08

1.1

1.0

—

Seborrhoeic dermatitis

223

1.94

4.05

1.2

1.1

—

27.24

—

Diplopia

325

1.76

3.99

1.0

1.1

—

13.84

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

340

1.74

3.98

1.2

1.1

—

27.24

—

Specific personality disorders

118

804

1.47

3.97

1.1

58.40

59.02

u/ml

—

Peripheral artery disease

137

769

1.44

3.95

1.1

—

29.60

—

Other disorders of fluid, electrolyte and acid-base balance

110

713

1.49

3.93

1.1

—

16.84

—

Atherosclerosis, excluding cerebral and coronary sclerosis

127

700

1.45

3.89

1.1

—

29.60

—

Progressive vascular leukoencephalopathy

2.99

3.86

1.2

1.1

—

GI-bleeding

112

761

1.47

3.82

1.2

1.1

—

25.74

—

Lesion of lateral popliteal nerve

2.44

3.81

1.3

1.1

—

Benign neoplasm of mouth and pharynx

287

1.79

3.76

1.1

—

27.24

—

Acne vulgaris

224

1.88

3.68

1.0

1.1

—

61.44

—

Otitis media, unspecified

327

1.70

3.67

1.1

1.2

—

57.00

—

Open wound of lower leg

387

1.66

3.66

1.1

—

35.04

—

Polyarteritis nodosa and related conditions

3.90

3.53

1.2

—

Ankylosing spondylitis, ICD10

236

1.83

3.47

1.2

1.1

—

27.24

—

Any dementia

573

0.59

3.33

1.1

—

36.60

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

225

1.83

3.32

1.2

1.1

—

55.04

—

Dementia, including avohilmo

731

0.64

3.31

1.1

—

36.60

—

Mononeuritis multiplex

9.01

3.31

1.0

—

Diabetic nephropathy

311

1.69

3.26

1.1

—

56.84

—

Other diseases of the digestive system

109

763

1.43

3.25

1.2

1.1

—

25.74

—

Multifocal fibrosclerosis

5.49

3.22

1.0

1.1

—

Discitis, unspecified

3.62

3.21

1.3

1.2

—

Fissure and fistula of anal and rectal regions

102

708

1.44

3.20

1.1

—

33.70

—

Cardiac murmurs and other cardiac sounds

255

1.75

3.16

1.1

—

36.03

—

Diabetic nephropathy, excluding more controls

264

1.68

3.15

1.1

—

50.33

—

Other specified and unspecified disorders of iris and ciliary body

7.77

3.08

1.0

—

Nail dystrophy

5.14

3.08

1.3

1.1

—

Guillain-Barre syndrome

3.28

3.07

1.1

—

Other CVD (FINNGEN)

164

1.83

2.99

1.1

—

Disorders in reading

3.04

2.98

1.3

1.1

—

Disorders of continuity of bone

271

1.71

2.97

1.0

1.1

—

29.87

—

Secondary hypertension

146

1.98

2.97

1.0

1.1

—

Dementia

657

0.65

2.87

1.1

—

36.60

—

Hypoplasia of dental enamel, prenatal

8.89

2.79

1.2

1.0

—

Cystic fibrosis

8.74

2.78

1.2

—

Other and unspecified nail disorders

2.74

2.73

1.0

1.1

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1082

0.70

2.71

1.3

1.1

—

38.27

—

Other immunodeficiencies

3.03

2.71

1.5

1.1

—

Selective deficiency of immunoglobulin G [IgG] subclasses

3.85

2.70

1.1

1.3

—

Superficial injury of ankle and foot

365

1.57

2.69

1.1

—

50.15

—

Other and unspecified mononeuropathies of lower limb

2.48

2.62

1.2

1.1

—

Hypoplasia of dental enamel, prenatal , including avohilmo

4.83

2.62

1.1

1.2

—

Mouth breathing

166

1288

1.29

2.62

1.2

1.1

—

41.71

—

ILD medications: pirfenidone

4.75

2.61

1.1

1.0

—

Malignant neoplasm of digestive organs

898

0.67

2.59

1.0

1.1

—

38.43

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.67

2.59

1.0

—

Spinal osteochondrosis

4.06

2.58

1.0

1.2

—

Systemic disorders of connective tissue in diseases classified elsewhere

7.35

2.57

1.2

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP)

245

1.68

2.56

1.2

1.1

—

58.03

—

Hypersensitivity angiitis

5.60

2.56

1.2

1.0

—

Amputation of foot

2.75

2.55

1.1

—

Diseases of male genital organs

164

637

1.30

2.54

1.2

1.1

—

74.89

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

292

1.62

2.53

1.2

1.1

—

55.04

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

974

0.72

2.50

1.1

—

41.44

—

Other and unspecified primary disorders of muscles

3.89

2.48

1.4

1.2

—

Other and unspecified acquired haemolytic anaemias

3.88

2.48

1.3

1.1

—

Melanoma in situ of other and unspecified parts of face

3.87

2.47

1.0

1.1

—

Other superficial mycoses

2.48

2.46

1.1

1.2

—

L02BA Anti-estrogens

583

0.60

2.44

1.3

1.1

—

40.20

—

Drug-induced osteoporosis

3.39

2.40

1.0

1.1

—

Other and unspecified localized connective tissue disorders

6.47

2.39

1.0

1.1

—

Carcinoma in situ of skin of lower limb, including hip

2.78

2.38

1.0

1.1

—

Dacryoadenitis

3.71

2.38

1.0

—

Urticaria due to cold and heat

3.70

2.38

1.1

1.2

—

Overexertion and strenuous or repetitive movements

266

1.62

2.37

1.3

1.1

—

27.24

—

In situ neoplasms

140

1080

1.30

2.37

1.1

—

43.12

—

Panniculitis, unspecified

4.17

2.37

1.1

—

Senile cataract

250

1271

1.22

2.35

1.1

—

49.31

—

Nasal polyp

469

1.45

2.31

1.1

—

47.17

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

300

1.57

2.30

1.2

1.1

—

58.03

—

Ectropion of eyelid

2.39

2.29

1.2

1.1

—

Other and unspecified disorders of orbit

4.74

2.29

1.3

1.1

—

Disorders of parathyroid gland, other and/or unspecified

4.70

2.28

1.7

1.2

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

649

0.64

2.28

1.1

—

37.43

—

Gangrene, not elsewhere classified

4.70

2.28

1.0

1.2

—

Meralgia paraesthetica

2.24

2.28

1.3

1.1

—

Alcohol use disorder, Swedish definition

203

1528

1.23

2.26

1.1

—

56.54

—

Defects in the complement system

3.18

2.25

1.7

1.2

—

Colonic or urogenital fistula

109

819

1.33

2.25

1.2

1.1

—

34.87

—

Type 2 diabetes, wide definition

331

1828

1.18

2.22

1.1

59.00

56.46

u/ml

—

Other and unspecified papulosquamous disorders

5.66

2.22

1.0

1.1

—

Other and unspecified drugs and medicaments

226

1.64

2.17

1.4

1.1

—

27.24

—

Other symptoms and signs involving the digestive system and abdomen

510

1.42

2.15

1.1

—

28.86

—

Melanocytic naevi

122

941

1.30

2.11

1.3

1.1

—

54.02

—

Skin changes due to chronic exposure to nonionizing radiation

117

848

1.31

2.11

1.1

—

32.33

—

Other protozoal intestinal diseases

2.59

2.11

1.1

1.2

—

Melanoma in situ of other and unspecified parts of face

3.25

2.10

1.0

1.1

—

Other papulosquamous disorders

3.24

2.10

1.0

1.1

—

Cushing syndrome

3.24

2.10

1.0

1.1

—

Contact with and exposure to communicable diseases

1190

0.74

2.10

1.1

—

62.90

—

Livedoid vasculitis

5.16

2.09

1.0

1.3

—

Selective deficiency of immunoglobulin A [IgA]y

5.12

2.08

1.0

1.2

—

Actinic keratosis

113

821

1.31

2.06

1.1

—

36.60

—

Intestinal stricture

105

797

1.32

2.05

1.2

1.1

—

32.37

—

Benign neoplasm: Rectum

424

1.44

2.03

1.1

—

36.80

—

Congenital malformations of heart and great arteries

387

1.46

2.01

1.1

—

36.03

—

Other noninfective disorders of lymphatic vessels and lymph nodes

2.06

2.01

1.2

1.1

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

178

1.69

1.98

1.1

—

46.24

—

Disease of hard tissues of teeth, NOS

3.37

1.97

1.1

—

Intracranial injury

223

1795

1.20

1.96

1.2

1.1

—

49.66

—

Haemorrhoids and perianal venous thrombosis

742

1.32

1.95

1.2

1.1

—

37.46

—

Other disorders of peripheral nervous system

3.83

1.95

1.2

1.1

—

Common variable immunodeficiency

3.82

1.95

1.2

—

Shock, not elsewhere classified

4.59

1.95

1.0

1.1

—

Malignant neoplasm of breast

164

1460

0.81

1.94

1.1

—

45.76

—

Pigmented purpuric dermatosis

3.80

1.94

1.0

1.1

—

Other acute viral hepatitis

2.76

1.94

1.1

—

Other and unspecified mood [affective] disorders

195

1.65

1.93

1.1

—

61.44

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

497

1.39

1.90

1.1

1.2

—

36.03

—

Persons encountering health services in other circumstances

151

1213

1.25

1.90

1.3

1.1

—

45.07

—

Calculus of kidney and ureter

100

764

1.31

1.89

1.1

—

30.31

—

Other and unspecified pemphigoid

3.24

1.89

1.0

1.1

—

Infection of intervertebral disc (pyogenic)

3.22

1.88

1.3

1.1

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

150

1217

0.80

1.88

1.1

—

45.48

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

150

1217

0.80

1.88

1.1

—

45.48

—

Malignant neoplasm of breast, HER2-negative

158

1431

0.81

1.87

1.1

—

47.75

—

Unspecified human immunodeficiency virus [HIV] disease

2.90

1.87

1.0

1.1

—

Other prurigo

2.89

1.87

1.5

1.1

—

Portal vein thrombosis

2.88

1.87

1.0

—

Drug-induced adrenocortical insufficiency

2.42

1.86

1.7

1.1

—

Otorrhagia

3.60

1.85

1.2

—

In situ neoplasms

140

1069

1.25

1.83

1.1

—

46.85

—

Ventral hernia

656

1.33

1.82

1.1

—

34.87

—

Infective dermatitis

270

1.52

1.81

1.5

1.1

—

27.24

—

Endometriosis diagnosis and infertility diagnosis occurring together

377

1.44

1.80

1.1

—

39.84

—

Melanocytic naevi

122

966

1.27

1.77

1.3

1.1

—

59.02

—

Varicose veins

248

1589

1.18

1.77

1.2

1.1

22.60

35.38

u/ml

—

Recurrent dislocation of patella

117

1.80

1.74

1.0

1.2

—

63.37

—

Disorders of optic nerve and visual pathways

281

1.50

1.74

1.3

1.1

—

27.24

—

Cervical root disorders

2.97

1.73

1.1

—

Other or unspecified immunodeficiency

3.95

1.73

1.4

1.2

—

Inflammation of lacrimal passages (chronic)

2.69

1.73

1.0

—

Benign neoplasm: Endocrine pancreas

3.91

1.72

1.0

1.1

—

Polyarteritis nodosa

3.90

1.72

1.4

1.2

—

Endometriosis ASRM stages 3,4

109

858

1.27

1.68

1.2

1.1

—

47.24

—

Pemphigus

3.21

1.67

1.0

1.2

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

2.61

1.66

1.3

1.1

—

Urolithiasis

105

824

1.28

1.66

1.1

—

30.31

—

Redundant prepuce, phimosis and paraphimosis

382

1.41

1.65

1.1

—

50.20

—

Medicines for HER+ breast cancer

106

1304

0.79

1.65

1.2

1.1

—

36.71

—

Benign neoplasm: Eye, unspecified

3.65

1.63

1.6

1.2

—

Benign neoplasm: Eye, unspecified

3.65

1.63

1.6

1.3

—

Unspecified transport accident

3.65

1.62

1.4

1.1

—

Microscopic polyangiitis

3.64

1.62

1.0

1.3

—

Injuries to the neck

695

1.30

1.62

1.1

—

50.15

—

Other lesions of median nerve

2.16

1.61

1.0

1.1

—

Intercostal neuropathy

3.04

1.59

1.3

1.2

—

Myotonic disorders

3.04

1.59

1.7

1.2

—

Hypertrophy of breast in women and men

725

1.29

1.57

1.1

—

32.15

—

Mature T/NK-cell lymphomas, hilmo

2.45

1.54

1.3

1.1

—

Defect, injury or illness of neck

3.39

1.53

1.0

1.3

—

Benign neoplasm: Orbit, unspecified

3.39

1.53

1.0

1.1

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

431

0.65

1.51

1.2

1.1

—

36.80

—

Benign leiomyoma with endometriosis

529

1.33

1.50

1.1

—

37.17

—

Other facial nerve disorders

2.08

1.49

1.0

1.1

—

Vascular dementia (undefined)

0.00

1.49

0.0

1.0

—

Ovarian dysfunction

251

1.48

1.47

1.3

1.1

—

68.31

—

Anosmia

2.14

1.46

1.1

—

Substance use, excluding alcohol

575

1.31

1.46

1.1

—

45.36

—

Explicit fungal Sepsis

3.17

1.44

1.0

1.1

—

Lung cancer and mesothelioma

300

1.40

1.44

1.1

—

27.20

—

Migraine, unspecified, drug-induced

2.77

1.44

1.0

1.2

—

Toxic liver disease

2.33

1.43

1.8

1.1

—

Sequelae of injuries of upper limb

262

1.45

1.41

1.3

1.1

—

27.24

—

Diseases of spleen

2.27

1.40

1.2

1.1

—

Other and unspecified bullous disorders

2.44

1.40

1.0

1.1

—

Malignant neoplasm of breast, HER-positive

101

1235

0.80

1.39

1.1

—

36.71

—

Other benign neoplasm of uterus: Corpus uteri

2.64

1.37

1.2

1.1

—

Complications predominantly related to the puerperium

125

1028

1.22

1.37

1.2

1.1

—

58.09

—

Benign neoplasm: Endocrine pancreas

2.99

1.36

1.0

1.1

—

Tetraplegia

2.98

1.36

1.4

1.2

—

Synovial hypertrophy, not elsewhere classified

2.97

1.36

3.2

1.2

—

Hyperkinetic disorders (excl. ADHD)

2.07

1.36

1.4

1.2

—

Benign leiomyoma with endometriosis

539

1.30

1.34

1.1

—

39.84

—

Parapsoriasis

2.14

1.34

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

105

850

1.24

1.34

1.1

—

57.82

—

D07AA Corticosteroids, weak (group I)

487

1.32

1.33

1.1

—

59.02

—

Superficial injury of shoulder and upper arm

299

1.41

1.33

1.1

—

29.87

—

Schizophrenia, schizotypal and delusional disorders

1045

0.79

1.32

1.1

—

46.65

—

Other benign neoplasm of uterus: Corpus uteri

2.53

1.31

1.2

1.1

—

Benign neoplasm: Orbit, unspecified

2.82

1.29

1.0

1.1

—

Recurrent and persistent haematuria

2.81

1.29

1.0

1.1

—

Seborrhoeic keratosis

535

1.29

1.27

1.3

1.1

—

38.60

—

Follicular cysts of skin and subcutaneous tissue

509

1.30

1.27

1.1

—

34.87

—

Drug-induced polyneuropathy

2.43

1.25

1.5

1.2

—

2.43

1.25

1.0

1.1

—

Carcinoma in situ of skin of scalp and neck

2.24

1.24

1.0

1.1

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

102

1012

0.82

1.24

1.1

—

47.59

—

Puerperal sepsis

485

1.30

1.23

1.1

—

33.70

—

conjunctival degenerations and deposits

1.98

1.22

1.7

1.1

—

Benign neoplasm: Duodenum

1.98

1.22

1.5

1.1

—

Localized adiposity

2.68

1.22

1.2

—

Acute myeloid leukaemia

2.65

1.22

1.2

1.1

—

Pneumocystosis

2.18

1.22

1.1

—

Dislocation, sprain and strain of joints and ligaments at neck level

478

1.30

1.21

1.2

1.1

—

50.15

—

Kyphosis

2.32

1.19

1.0

1.2

—

Tic and related disorders

2.32

1.19

1.0

1.3

—

Burns and corrosions

384

1.33

1.18

1.1

—

29.87

—

Tonsillectomy and adenotomy

263

1619

1.13

1.17

1.2

1.1

47.04

66.29

u/ml

—

Postpartum care and examination

371

0.74

1.16

1.2

1.1

—

67.18

—

Dementia due to Parkinson's disease

0.00

1.16

0.0

1.1

—

Other superficial injuries of ankle and foot

2.53

1.15

1.2

—

Horner syndrome

0.00

1.15

0.0

1.1

—

Infliximab

2.53

1.15

1.0

1.2

—

Causalgia

2.06

1.15

2.3

1.1

—

Acidosis

2.06

1.15

1.0

1.1

—

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

2.52

1.15

1.2

1.1

—

Acute myeloid leukaemia, helper endpoint

2.52

1.15

1.2

1.1

—

Family history of malignant neoplasm

368

0.68

1.15

1.0

1.1

—

39.84

—

Early syphilis

2.35

1.13

1.3

1.1

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.35

1.12

1.1

1.2

—

Abscess of lung

2.35

1.12

1.0

1.1

—

Malignant neoplasm of testis

2.35

1.12

1.3

1.0

—

Other injuries of upper limb, level unspecified

2.28

1.11

1.0

1.1

—

Intentional self-harm by unspecified means

2.28

1.10

1.0

1.2

—

Tularaemia

2.28

1.10

1.3

1.2

—

Schizophrenia or delusion

1041

0.82

1.10

1.1

—

46.65

—

Ovarian dysfunction, other/unspecified

2.41

1.09

1.4

1.2

—

Acute inflammation of orbit

2.41

1.09

1.6

1.0

—

Heterophoria

243

1.40

1.09

1.1

—

33.84

—

Dislocation, sprain and strain of joints and ligaments of knee

254

2098

1.13

1.08

1.2

1.1

40.80

63.21

u/ml

—

Other lack of coordination

2.20

1.08

1.0

1.2

—

Testicular dysfunction

1.87

1.07

1.0

1.1

—

Viral pneumonia (known virus, not influenza)

1.93

1.06

1.0

1.1

—

Complications of labour and delivery

263

1645

0.89

1.06

1.1

82.37

49.00

u/ml

—

Localized skin eruption due to drugs and medicaments

2.14

1.06

1.1

1.2

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

2.13

1.05

1.3

1.0

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

591

0.76

1.05

1.2

1.1

—

31.20

—

Acute myringitis

2.30

1.04

1.2

1.1

—

Contracture of joint

2.29

1.03

1.2

1.1

—

Disorders of porphyrin and bilirubin metabolism

2.08

1.03

1.6

1.1

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.02

1.00

1.1

1.2

—

Cicatricial alopecia [scarring hair loss]

2.20

0.98

1.4

1.1

—

Carcinoma in situ of vulva

2.20

0.98

1.0

1.1

—

Abnormality of white blood cells, not elsewhere classified

2.19

0.98

1.0

1.1

—

Glaucoma secondary to eye inflammation

2.19

0.98

1.0

1.2

—

Acquired stenosis of external ear canal

2.19

0.98

1.0

1.1

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

0.00

0.98

0.0

1.0

—

Lesion of radial nerve

1.75

0.96

1.0

1.1

—

Fitting and adjustment of other devices

103

806

1.19

0.96

1.1

—

20.03

—

Unspecified threat to breathing

2.24

0.94

1.0

1.1

—

Acquired absence of organs, not elsewhere classified

2.24

0.94

1.2

1.1

—

Colitis, primary sclerosing, strict definition

2.16

0.92

1.2

1.1

—

Car occupant injured in other and unspecified transport accidents

580

1.23

0.92

1.1

—

50.15

—

Fracture of shoulder and upper arm

122

1049

1.16

0.90

1.1

—

45.35

—

Other chondrocalcinosis

2.09

0.89

1.0

1.1

—

Tic disorders

2.08

0.89

1.0

1.3

—

Tuberculosis of other organs

1.87

0.87

1.1

—

Vulvovaginal ulceration/inflammation in other diseases

187

1.39

0.85

1.1

—

58.03

—

Carcinoma in situ of skin of scalp and neck

1.79

0.84

1.0

1.1

—

Alcohol use disorder, ICD-based

137

1197

1.15

0.84

1.1

—

51.71

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.88

0.82

1.0

1.2

—

Malignant neoplasm of breast, HER-negative

698

0.81

1.1

—

41.75

—

Other drug-induced secondary parkinsonism

0.00

0.79

0.0

1.1

—

Alcohol induced polyneuropathy

0.00

0.79

0.0

1.1

—

Secondary malignant neoplasm of other and unspecified sites

0.00

0.79

0.0

1.0

—

Isolated proteinuria with specified morphological lesion

1.83

0.79

1.0

1.1

—

Dementia due to Parkinsons disease, excluding more controls

0.00

0.79

0.0

1.1

—

Sequelae of other accidents

1.83

0.79

1.5

1.1

—

Other interventions on the root canals of the tooth

1.67

0.79

1.0

1.1

—

Malignant neoplasm of parotid gland

0.00

0.79

0.0

1.2

—

Other specified/unspecified disorders of bone/cartilage

1.67

0.79

1.2

1.1

—

Acute and transient psychotic disorders

362

0.74

0.79

1.0

1.1

—

27.24

—

Flatulence and related conditions

0.00

0.78

0.0

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

116

1008

1.15

0.78

1.1

—

37.89

—

Fracture of skull and facial bones

583

1.20

0.78

1.1

—

29.87

—

Other disorders originating in the perinatal period

1.78

0.76

1.2

1.1

—

Tic and related disorders

1.77

0.76

1.0

1.2

—

Hypersensitivity pneumonitis due to organic dust

1.77

0.76

1.2

1.1

—

Hypertrophy of breast

668

1.18

0.76

1.1

—

32.15

—

Benign neoplasm of ovary

604

1.19

0.75

1.1

—

25.84

—

Benign neoplasm of ovary

604

1.19

0.75

1.1

—

35.65

—

Testicular hypofunction

1.70

0.75

1.0

1.1

—

Unspecified parasitic disease

2.10

0.75

1.6

1.1

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

2.10

0.75

1.0

1.1

—

Burns and corrosions of multiple and unspecified body regions

1.67

0.74

1.1

—

Gout due to impairment of renal function

2.01

0.73

1.0

1.1

—

Emotional disorders starting during childhood or adolecense, excluding more controls

114

1.46

0.73

1.1

1.3

—

92.64

—

Family history of other specific disorders

1.81

0.72

1.0

1.2

—

Guttate psoriasis

1.81

0.72

1.0

1.1

—

Hyphaema and other vascular disorders of iris and ciliary body

1.80

0.72

1.0

1.1

—

Embolic stroke with flimmer

1.80

0.72

1.0

1.1

—

Behavioural disorders

1.61

0.72

1.0

1.2

—

Mental disorders, not otherwise specified

255

1.30

0.71

1.1

—

33.84

—

Nonalcoholic steatohepatitis

1.94

0.71

1.0

1.2

—

Deep endometriosis

309

1.26

0.70

1.1

—

39.84

—

Blood alcohol or alcohol intoxication level

1.56

0.70

1.0

1.1

—

Burns and corrosions of external body surface, specified by site

283

1.27

0.69

1.1

—

33.64

—

Fistulae involving female genital tract

1.67

0.68

1.0

1.1

—

Certain conditions originating in the perinatal period

267

1.26

0.68

1.1

1.2

—

80.57

—

Vascular dementia

114

0.59

0.68

1.0

1.1

—

Amputation of thigh

1.63

0.67

1.0

1.1

—

Other congenital malformations, not elsewhere classified

1.80

0.66

1.0

1.1

—

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

1.80

0.66

1.0

1.1

—

Benign neoplasm: Oesophagus

1.79

0.66

1.6

1.1

—

Erosion and ectropion of cervix uteri

1.58

0.65

1.1

—

Chronic myeloproliferative disease

1.73

0.64

1.2

1.1

—

Universal erythroderma, KELA reimbursement

1.73

0.64

1.4

1.1

—

Injury of eye and orbit

386

1.22

0.64

1.1

—

29.87

—

Dependence on enabling machines and devices, not elsewhere classified

1.72

0.63

1.2

1.1

—

Leisure time condition

503

0.81

0.63

1.1

—

29.87

—

Problems related to lifestyle

261

1.27

0.62

1.1

—

29.87

—

Carcinoma in situ of vulva

1.68

0.61

1.0

1.1

—

Congenital musculoskeletal deformities of head, face, spine and chest

1.67

0.61

1.0

1.2

—

Dental pulpitis 3

351

1.19

0.61

1.2

—

94.90

—

Mastocytosis

0.00

0.60

0.0

1.2

—

Congenital malformations of cardiac chambers and connections

0.00

0.60

0.0

1.2

—

Other congenital malformations of male genital organs

0.00

0.60

0.0

1.0

—

Mandibular prognathia AND surgery (LeFortI or BSSRO)

0.00

0.60

0.0

1.2

—

Severe visual impairment, monocular

0.00

0.60

0.0

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

145

1306

1.11

0.59

1.1

—

59.09

—

Cleft lip and cleft lip and palate

0.00

0.59

0.0

1.2

—

Injury of nerves and spinal cord at neck level

1.54

0.59

1.1

—

Melanoma of uvea

0.00

0.59

0.0

1.1

—

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.59

0.0

1.1

—

Other puerperal infections

272

1.25

0.59

1.3

1.1

—

58.03

—

L02BG Aromatase inhibitors

1024

0.88

0.59

1.1

—

33.68

—

Embolic stroke

1.45

0.58

1.3

1.1

—

Kela-code for behavioural disturbances in mental retardation

0.00

0.58

0.0

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs

0.00

0.58

0.0

1.1

—

Tuberculosis of other organs, strict

1.51

0.58

1.1

—

Other and unspecified acne

1.72

0.58

1.2

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

798

0.87

0.57

1.1

1.2

—

41.22

—

Use of galantamine

115

0.61

0.57

1.0

1.1

—

Anxious personality disorder

1.49

0.57

1.0

1.2

—

Paraplegia, diplegia of upper limbs

1.49

0.57

1.1

—

Disorders of globe

1.49

0.57

1.0

1.1

—

Cellulitis of external ear

1.68

0.57

1.2

1.1

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.67

0.57

1.0

1.2

—

Poor fetal growth

457

1.18

0.56

1.2

1.1

—

71.36

—

Abscess of external ear

1.63

0.55

1.3

1.1

—

Oral leukoplakia

1.63

0.55

1.2

1.1

—

Rheumatic fever incl heart disease

1.54

0.55

1.1

—

Maternal care for known or suspected abnormality of pelvic organs

726

0.88

0.55

1.2

—

68.09

—

Prolapse and hernia of ovary and fallopian tube

1.49

0.54

1.0

1.1

—

Other and unspecified mononeuropathies of upper limb

1.48

0.53

1.7

1.1

—

Open wound of forearm

231

1.26

0.53

1.1

—

33.64

—

Exposure to other and unspecified man-made environmental factors

1.54

0.53

1.0

1.1

—

Suppurative otitis media, unspecified

1.46

0.53

1.0

1.2

—

Evidence of alcohol involvement determined by blood alcohol level

1.51

0.51

1.0

1.2

—

Carcinoma in situ of skin of upper limb, including shoulder

1.50

0.51

1.0

1.1

—

Open wound of hip and thigh

1.41

0.51

1.0

1.1

—

Alcohol dependence

703

0.87

0.50

1.1

—

44.74

—

Other congenital malformations of peripheral vascular system

1.47

0.50

1.0

1.2

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

1.47

0.50

1.3

1.1

—

Injuries to the hip and thigh

144

1202

1.10

0.50

1.1

—

44.85

—

Dental pulpitis 3, only avohilmo

331

1.17

0.49

1.1

1.2

—

94.90

—

Disorder of the sleep-wake schedule

1.56

0.49

2.3

1.2

—

Carcinoma in situ of cervix uteri

312

0.80

0.48

1.1

—

58.03

—

Carcinoma in situ of other and unspecified digestive organs

1.49

0.47

1.0

—

Unstable angina pectoris

104

776

1.11

0.47

1.1

—

38.43

—

Postpartum haemorrhage

928

0.90

0.45

1.1

1.2

—

45.67

—

Non-small cell lung cancer, squamous

0.60

0.45

1.0

1.1

—

Non-small cell lung cancer, squamous, helper endpoint

0.60

0.45

1.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

385

1.17

0.44

1.2

1.1

—

27.24

—

Diabetes medication

404

2576

0.95

0.42

1.1

50.37

63.85

u/ml

—

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

Foreign body in genitourinary tract

1.52

0.41

1.0

1.2

—

Carcinoma in situ of endometrium

0.00

0.41

0.0

1.2

—

Other factor of the environment

1.52

0.41

1.2

1.1

—

Toxoplasmosis

0.00

0.41

0.0

1.3

—

Toxic effect of other gases, fumes and vapours

0.00

0.41

0.0

1.2

—

Xerosis cutis

1.52

0.41

1.0

1.1

—

Cardiomyopathies, Secondary/extrinsic

0.00

0.41

0.0

1.1

—

Benign lipomatous neoplasm

889

1.10

0.41

1.1

—

39.47

—

Pulmonary oedema

1.52

0.41

1.2

1.1

—

Other specified and unspecified disorders of lens

0.00

0.41

0.0

1.1

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.41

0.0

1.1

—

Malignant neoplasm of base of tongue

0.00

0.41

0.0

1.1

—

Melanoma in situ of lower limb, including hip

0.00

0.41

0.0

1.2

—

Melanoma in situ of lower limb, including hip

0.00

0.41

0.0

1.1

—

Intentional self-harm by jumping from a high place

0.00

0.41

0.0

1.1

—

Benign neoplasm: Ill-defined sites within the digestive system

0.00

0.41

0.0

1.3

—

Cleft lip and palate

0.00

0.41

0.0

1.1

—

Ductal carcinoma of pancreas

0.00

0.41

0.0

1.2

—

Malignant neoplasm of nasal cavity and sinuses

0.00

0.41

0.0

1.1

—

Deformity of finger(s)

0.00

0.41

0.0

1.3

—

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

Injury of cranial nerves

0.00

0.41

0.0

1.1

—

Benign neoplasm: Connective and other soft tissue of thorax

0.00

0.41

0.0

1.1

—

Benign neoplasm: Brain, infratentorial

0.00

0.41

0.0

1.2

—

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

Other or unspecified paralytic strabismus

0.00

0.41

0.0

1.2

—

Other and unspecified spinal muscular atrophies

0.00

0.41

0.0

1.2

—

Cerebral atherosclerosis

0.00

0.40

0.0

1.1

—

Carcinoma in situ of cervix uteri

304

0.82

0.40

1.1

—

58.03

—

Pervasive developmental disorders excl. Autism + Asperger

1.47

0.40

1.2

1.1

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.40

0.0

1.2

—

Malignant neoplasm of retroperitoneum and peritoneum

0.00

0.40

0.0

1.2

—

Fasciculation

1.43

0.39

1.0

1.1

—

Benign neoplasm: Ill-defined sites within the digestive system

0.00

0.39

0.0

1.2

—

Benign neoplasm: Brain, unspecified

0.00

0.39

0.0

1.2

—

Benign neoplasm: Brain, unspecified

0.00

0.39

0.0

1.2

—

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.2

—

Benign neoplasm: Uterine tubes and ligaments

0.00

0.39

0.0

1.2

—

Benign neoplasm: Uterine tubes and ligaments

0.00

0.39

0.0

1.2

—

Effects of heat and light

0.00

0.39

0.0

1.1

—

Status post-ami

0.70

0.37

1.0

1.1

—

Open wound of thorax

1.35

0.37

1.0

1.1

—

Other complications of labour and delivery, not elsewhere classified

387

1.15

0.37

1.1

—

60.11

—

Benign lipomatous neoplasm

896

1.09

0.37

1.1

—

30.31

—

Injury of urinary and pelvic organs

1.43

0.35

1.0

1.1

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

0.63

0.35

1.0

1.1

—

Male infertility

0.62

0.35

1.4

1.1

—

Carcinoma in situ of skin of upper limb, including shoulder

1.31

0.33

1.0

1.1

—

1.31

0.33

1.3

1.1

—

Unspecified lump in breast

578

1.11

0.32

1.1

—

39.84

—

Melanocytic naevi of trunk

341

1.14

0.32

1.3

1.1

—

27.24

—

Inflammatory disorders of breast

211

1.19

0.31

1.1

—

55.04

—

Other and unspecified mononeuropathies, also in other diseases

1.25

0.29

1.3

1.1

—

Maternal care for other known or suspected fetal problems

665

0.93

0.29

1.1

1.2

—

69.36

—

Mandibular retrognathia

203

1.18

0.29

1.2

1.1

—

33.84

—

Postpartum hemorraghe, all women as controls

1026

0.93

0.27

1.1

—

65.83

—

Presence of other devices

550

0.91

0.25

1.1

—

27.89

—

Combinations of oral blood glucose lowering drugs

768

0.92

0.25

1.1

—

45.00

—

Diabetes mellitus

436

2523

1.03

0.24

1.1

59.04

61.74

u/ml

—

Chalazion

302

1.13

0.24

1.1

—

27.24

—

Third [oculomotor] nerve palsy

1.32

0.23

1.0

1.1

—

Contact with lifting and transmission devices, not elsewhere classified

1.32

0.23

1.0

1.1

—

Assault by blunt object

1.28

0.23

1.0

1.2

—

Contact with other hot metals

1.28

0.23

1.2

1.1

—

Lesion of sciatic nerve

1.25

0.22

1.1

—

Other noninflammatory disorders of cervix uteri

125

1.20

0.22

1.1

—

Tuberous sclerosis 1

0.00

0.21

0.0

1.1

—

Syndactyly

0.00

0.21

0.0

1.0

—

Other and unspecified cicatricial alopecia

0.00

0.21

0.0

1.1

—

Other acantholytic disorders

0.00

0.21

0.0

1.2

—

Osteogenesis imperfecta

0.00

0.21

0.0

1.1

—

Other degenerative disorders of eyelid and periocular area

0.00

0.21

0.0

1.1

—

Drug-induced dystonia

0.00

0.21

0.0

1.2

—

Labyrinthine fistula

0.00

0.21

0.0

1.2

—

Congenital ichthyosis

0.00

0.21

0.0

1.2

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.21

0.0

1.3

—

Hypertrophy of bone

0.00

0.21

0.0

1.2

—

Benign neoplasm: Mediastinum

0.00

0.21

0.0

1.1

—

Cleft lip

0.00

0.21

0.0

1.4

—

Disorders of aromatic amino-acid metabolism

0.00

0.21

0.0

1.1

—

Cerebral amyloid angiopathy

0.00

0.21

0.0

1.1

—

Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Open wounds involving multiple body regions

0.00

0.21

0.0

1.2

—

Alcohol abuse counselling and surveillance

1.19

0.21

1.0

1.1

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

0.21

0.0

1.1

—

Brain astrocytoma

0.00

0.21

0.0

1.2

—

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Benign neoplasm: Lower jaw bone

0.00

0.21

0.0

1.1

—

Carcinoma in situ of endometrium

0.00

0.21

0.0

1.1

—

Female infertility, uterine origin

0.00

0.21

0.0

1.1

—

Exposure to ignition of highly flammable material

0.00

0.21

0.0

1.1

—

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Other operation for atrial fibrillation

0.00

0.21

0.0

1.1

—

Tracheo-bronchomalasia

0.00

0.21

0.0

1.1

—

Frontotemporal dementia

0.00

0.21

0.0

1.0

—

Malignant neoplasm of renal pelvis

0.00

0.21

0.0

1.1

—

Hydrocephalus in other diseases

0.00

0.21

0.0

1.2

—

Disorders of other and unspecified cranial nerves

0.00

0.21

0.0

1.2

—

Vascular dementia (other)

0.00

0.21

0.0

1.0

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.21

0.0

1.0

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.21

0.0

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

749

1.07

0.21

1.0

1.1

—

39.60

—

Down's syndrome

0.00

0.21

0.0

1.3

—

Malignant neoplasm of adrenal gland

0.00

0.21

0.0

1.3

—

Complications of anaesthesia during labour and delivery

0.00

0.21

0.0

1.3

—

Hair colour and hair shaft abnormalities

0.00

0.21

0.0

1.2

—

Nondiabetic hypoglycaemic coma

0.00

0.21

0.0

1.2

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.21

0.0

1.1

—

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Chromophobe cell carcinoma of kidney

0.00

0.21

0.0

1.2

—

Blindness or visual impairment, binocular

0.00

0.21

0.0

1.1

—

Cardiomyopathy in other diseases

0.00

0.21

0.0

1.0

—

Malignant neoplasm of other and ill-defined digestive organs

0.00

0.21

0.0

1.1

—

Unattended death

0.00

0.21

0.0

1.2

—

Adhesive middle ear disease

1.16

0.21

1.0

1.2

—

Congenital malformations of ear causing impairment of hearing

0.00

0.21

0.0

1.2

—

Osteosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Left side

0.00

0.21

0.0

1.3

—

Benign neoplasm: Lower jaw bone

0.00

0.21

0.0

1.1

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.21

0.0

1.1

—

Drowning and submersion while in natural water

0.00

0.21

0.0

1.2

—

Adenocarcinomas of cervix

0.00

0.21

0.0

1.2

—

Other proliferative retinopathy

0.00

0.21

0.0

1.2

—

Malignant neoplasm of nasal cavity and middle ear

0.00

0.21

0.0

1.2

—

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Other/unspecified mastoiditis and related conditions

0.00

0.21

0.0

1.1

—

Alcoholic cardiomyopathy

0.00

0.21

0.0

1.1

—

Familial erythrocytosis

0.00

0.21

0.0

1.2

—

Cleft hard palate NOS

0.00

0.21

0.0

1.2

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

0.21

0.0

1.2

—

Nosocomial condition (hospital)

0.00

0.21

0.0

1.2

—

Moderate mental retardation

0.00

0.21

0.0

1.2

—

Bullous keratopathy

0.00

0.21

0.0

1.2

—

Use of entacapone

0.00

0.21

0.0

1.1

—

Benign neoplasm: Connective and other soft tissue of thorax

0.00

0.20

0.0

1.2

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.20

0.0

1.1

—

Right side

0.00

0.20

0.0

1.1

—

Benign neoplasm: Brain, infratentorial

0.00

0.20

0.0

1.2

—

Liposarcoma

0.00

0.20

0.0

1.1

—

Diastasis of muscle

0.00

0.20

0.0

1.1

—

Sequelae of poliomyelitis

0.00

0.20

0.0

1.1

—

Complications following myocardial infarction

0.00

0.20

0.0

1.1

—

Other bursitis, not elsewhere classified

0.00

0.20

0.0

1.1

—

Malignant neoplasm of small intestine

1.25

0.20

1.2

1.1

—

Diabetes, varying definitions

432

2514

1.03

0.20

1.1

50.37

63.85

u/ml

—

Malignant neoplasm, without specification of site

1.23

0.20

1.0

1.1

—

Other congenital malformations

278

1.12

0.20

1.0

1.1

—

33.84

—

Other and specified injuries of hip and thigh

1.15

0.19

1.0

1.1

—

Nontoxic goitre/thyroid nodule

105

998

1.05

0.18

1.1

—

36.82

—

Carcinoma in situ of skin of trunk

1.21

0.18

1.3

1.0

—

Arterial embolism and thrombosis of lower extremity artery

1.13

0.17

1.0

1.1

—

Carcinoma in situ of skin of trunk

1.11

0.17

1.3

1.1

—

Crowding of teeth, including avohilmo

264

0.91

0.17

1.2

1.1

—

47.70

—

Acute appendicitis, with complications

597

0.94

0.16

1.3

1.1

—

34.87

—

FESS (DNB20)

369

0.92

0.15

1.1

—

27.24

—

Noise effects on inner ear

1.13

0.15

1.3

1.1

—

Cardiac arrest

1.18

0.14

1.1

—

Superficial injury of hip and thigh

334

1.08

0.13

1.1

—

29.87

—

Postpartum hemorraghe, parous women as controls

875

0.96

0.13

1.1

1.2

—

61.47

—

Retained placenta and membranes, without haemorrhage

472

1.06

0.12

1.2

1.1

—

20.60

—

Postpartum haemorrhage due to anatomy

346

1.07

0.12

1.2

1.1

—

71.15

—

Pedal cyclist injured in noncollision transport accidents

322

0.93

0.11

1.2

1.1

—

27.24

—

Schizophrenia or delusion, excluding more controls

875

0.96

0.10

1.1

—

69.78

—

Other fall from one level to another

643

1.04

0.10

1.1

—

52.69

—

Rheumatic valve diseases

1.09

0.09

1.2

1.1

—

Secondary polycythaemia

1.06

0.09

1.2

1.1

—

Contact with sharp object, undetermined intent

1.11

0.09

1.0

1.1

—

Burn and corrosion of hip and lower limb, except ankle and foot

1.09

0.09

1.3

1.2

—

Gestational diabetes (for exclusion)

155

1122

0.98

0.09

1.1

1.2

—

65.68

—

Secondary parkinsonism

1.03

0.08

1.7

1.1

—

Other intracranial haemorrhages

1.08

0.08

1.1

—

Other and unspecified injuries of lower leg

193

0.93

0.06

1.2

1.1

—

35.04

—

Nontoxic multinodular goitre

577

0.97

0.05

1.1

—

26.20

—

Salpingitis and oophoritis

674

1.02

0.04

1.2

1.1

—

40.42

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

204

1213

0.99

0.04

1.1

1.2

61.24

61.89

u/ml

—

Other and unspecified nonorganic psychotic disorders

622

0.98

0.03

1.0

1.1

—

45.36

—

Pedal cyclist injured in other and unspecified transport accidents

310

0.97

0.03

1.1

—

27.24

—

Ethmoidectomy

384

1.02

0.00

1.1

—

27.24

—

Diabetic retinopathy, strict definition

364

1.01

0.00

1.1

—

50.33

—

Postpartum haemorrhage due to retained placenta

429

1.00

0.00

1.0

1.1

—

71.15

—

Gestational [pregnancy-induced] hypertension

105

1044

1.00

0.00

1.2

1.1

—

45.40

—

Non-allergic asthma

236

1.02

0.00

1.3

1.1

—

49.40

—

Pneumoconiosis due to dust containing silica

0.00

0.0

1.0

—

Accident to watercraft causing drowning and submersion

0.00

0.0

1.2

—

Choroidal haemorrhage and rupture

0.00

0.0

1.0

—

Fetus and newborn affected by other complications of labour and delivery

0.00

0.0

1.1

—

Hereditary choroidal dystrophy

0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

0.0

1.1

—

Fetal blood loss

0.00

0.0

1.2

—

Fluid overload

0.00

0.0

1.1

—

Congenital myopathies

0.00

0.0

1.3

—

Other and unspecified postprocedural disorders of eye and adnexa

0.00

0.0

1.0

—

Erythema annulare centrifugum

0.00

0.0

1.2

—

Injury of blood vessels at hip and thigh level

0.00

0.0

1.1

—

Marasmic kwashiorkor

0.00

0.0

1.1

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.0

1.0

—

Noninfective disorders of pinna

0.00

0.0

1.1

—

Polyp of middle ear

0.00

0.0

1.0

—

Other cestode infections

0.00

0.0

1.2

—

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

0.00

0.0

1.1

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.0

1.3

—

Malignant neoplasm of trachea, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Drug-induced hypopituitarism

0.00

0.0

1.0

—

Sunburn

0.00

0.0

1.1

—

Benign neoplasm: Epididymis

0.00

0.0

1.1

—

Periodontosis

0.00

0.0

1.0

—

Sleep terrors [night terrors]

0.00

0.0

1.3

—

Testicular dysfunction, other/unspecified

0.00

0.0

1.2

—

Abuse of non-dependence-producing substances

0.00

0.0

1.2

—

Choroidal detachment

0.00

0.0

1.2

—

Disorders of tyrosine metabolism

0.00

0.0

1.2

—

Hirsutism, drug-induced

0.00

0.0

1.4

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

0.0

1.2

—

Lipoprotein deficiency

0.00

0.0

1.4

—

Epileptic seizures related to drugs

0.00

0.0

1.1

—

Transient acantholytic dermatosis [Grover]

0.00

0.0

1.2

—

Diseases of thymus

0.00

0.0

1.3

—

Erythrasma

0.00

0.0

1.2

—

Radiodermatitis

0.00

0.0

1.0

—

Thoracic root disorders

0.00

0.0

1.0

—

Drug-induced acute pancreatitis

0.00

0.0

1.4

—

Other disorders of bone development and growth

0.00

0.0

1.0

—

Perioral dermatitis, drug-induced

0.00

0.0

1.1

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.0

1.3

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

0.0

1.0

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

0.0

1.2

—

Defect, injury or illness of lumbar spine

0.00

0.0

1.1

—

Other hypertrophic osteoarthropathy

0.00

0.0

1.0

—

Venous complications and haemorrhoids in pregnancy

0.91

0.00

1.0

1.2

—

Carcinoma in situ of other and unspecified sites

0.97

0.00

1.3

1.1

—

Pseudopolyposis of colon

0.00

0.0

1.1

—

Carcinoma in situ of oral cavity

0.00

0.0

1.4

—

Immunodeficiency associated with other major defects

0.00

0.0

1.1

—

Traumatic spondylopathy

0.00

0.0

1.3

—

Small kidney of unknown cause

0.00

0.0

1.2

—

Benign neoplasm: Skin of upper limb, including shoulder

1.02

0.00

1.2

1.1

—

Carcinoma in situ, bladder

0.91

0.00

1.2

1.1

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.0

1.0

—

Eccrine sweat disorders

0.00

0.0

1.1

—

Other hyperalimentation

0.00

0.0

1.3

—

Telogen effluvium

0.00

0.0

1.1

—

Malignant neoplasm of vagina

0.00

0.0

1.3

—

Secondary parkinsonism+Parkinsonism in other disease

1.02

0.00

1.7

1.1

—

Upper arm

0.00

0.0

1.1

—

Dysplastic lesion of the vagina of unknown severity

0.00

0.0

1.4

—

Unspecified multiple injuries

0.00

0.0

1.3

—

Benign neoplasm: Ciliary body

0.00

0.0

1.1

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

Benign neoplasm: Aortic body and other paraganglia

0.00

0.0

1.0

—

Benign neoplasm: Larynx

0.97

0.00

1.0

1.1

—

Other inherited muscular atrophy

0.00

0.0

1.3

—

Benign neoplasm: Liver/bile ducts (ICD-9)

0.00

0.0

1.0

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.1

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.00

0.0

1.1

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

0.0

1.2

—

Benign neoplasm: Cornea

0.00

0.0

1.2

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.0

1.1

—

Disorders of muscle tone of newborn

0.00

0.0

1.2

—

Malignant neoplasm of ureter

0.00

0.0

1.0

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

0.92

0.00

1.0

1.1

—

Obstetric embolism

0.00

0.0

1.1

—

Combined immunodeficiency, unspecified

0.00

0.0

1.2

—

0.00

0.0

1.1

—

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Benign neoplasm: Epididymis

0.00

0.0

1.1

—

Other and unspecified water transport accidents

0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

0.0

1.1

—

Adenocarcinoma of small intestine

0.00

0.0

1.2

—

Dislocations, sprains and strains involving multiple body regions

0.00

0.0

1.2

—

Intentional self-harm by drowning and submersion

0.00

0.0

1.3

—

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

0.00

0.0

1.4

—

Burn and corrosion of respiratory tract

0.00

0.0

1.3

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.0

1.0

—

Injury of blood vessels at forearm level

0.00

0.0

1.2

—

Complications of anaesthesia during pregnancy

0.00

0.0

1.4

—

Injury of heart

0.00

0.0

1.2

—

Injury of blood vessels at shoulder and upper arm level

0.00

0.0

1.2

—

Malignant neoplasm of lip

0.00

0.0

1.0

—

Malignant neoplasm of penis

0.00

0.0

1.0

—

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Ependymoma

0.00

0.0

1.0

—

Benign neoplasm: Mediastinum

0.00

0.0

1.1

—

Birth injury to peripheral nervous system

0.00

0.0

1.1

—

Traumatic cerebral oedema

0.00

0.0

1.2

—

Intracranial laceration and haemorrhage due to birth injury

0.00

0.0

1.2

—

Other birth injuries

0.00

0.0

1.0

—

Osteosarcoma

0.00

0.0

1.0

—

0.00

0.0

1.1

—

Use of bromocriptine

0.00

0.0

1.1

—

Congenital malformations of nose

0.00

0.0

1.3

—

Acquired atrophy of ovary and fallopian tube

0.00

0.0

1.0

—

Miliaria rubra

0.00

0.0

1.0

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.0

1.0

—

Congenital absence, atresia and stenosis of small intestine

0.00

0.0

1.0

—

Malignant neoplasm of gum

0.00

0.0

1.2

—

Neuroendocrine tumor and carcinoma of rectum

0.00

0.0

1.1

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Traumatic amputation of ankle and foot

0.00

0.0

1.3

—

Use of trihexyphenidyl

0.00

0.0

1.2

—

Malignant neoplasm of gallbladder

0.00

0.0

1.1

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

0.0

1.0

—

Cyst of spleen

0.00

0.0

1.2

—

Spina bifida

0.00

0.0

1.0

—

Congenital malformations of lung

0.00

0.0

1.2

—

Bradycardia, unspecified, drug-induced

0.00

0.0

1.2

—

Neurofibromatosis, type 2

0.00

0.0

1.1

—

Motorcycle rider injured in noncollision transport accidents

0.91

0.00

1.0

1.1

—

Other and unspecified disorders of sclera

0.00

0.0

1.2

—

Post-traumatic hydrocephalus, unspecified

0.00

0.0

1.0

—

Craniosynostosis EXCLUDE syndromes

0.00

0.0

1.2

—

Vascular dementia (sudden onset)

0.00

0.0

1.0

—

Carcinoma in situ, bladder

0.95

0.00

1.2

1.1

—

conjunctival scars

0.00

0.0

1.3

—

Moyamoya

0.00

0.0

1.2

—

Exposure to excessive natural heat

0.00

0.0

1.0

—

Intentional self-harm by smoke, fire and flames

0.00

0.0

1.1

—

Abnormal pulmonary venous return

0.00

0.0

1.2

—

Restrictive cardiomyopathy

0.00

0.0

1.0

—

Exposure to controlled fire, not in building or structure

0.00

0.0

1.1

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.0

1.2

—

Abscess of mediastinum

0.00

0.0

1.0

—

Lens-induced iridocyclitis

0.00

0.0

1.2

—

Phantom limb syndrome

0.00

0.0

1.0

—

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

ILD medications: acetylcysteine

0.00

0.0

1.0

—

Oesophagitis, drug-induced

0.00

0.0

1.4

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.0

—

Unspecified event, undetermined intent

0.85

0.00

1.2

1.1

—

Cerebral oedema

0.00

0.0

1.2

—

Chondrosarcoma

0.00

0.0

1.0

—

Benign neoplasm: Ciliary body

0.00

0.0

1.1

—

Disorders of vagus nerve

0.00

0.0

1.2

—

Physiological and behavioural disorders associated with sexual development and orientation

0.00

0.0

1.2

—

Toxic encephalopathy

0.00

0.0

1.0

—

Acanthosis nigricans

0.00

0.0

1.3

—

Carcinoma in situ of oral cavity

0.00

0.0

1.3

—

Carcinoma in situ of larynx

0.00

0.0

1.0

—

Other and unspecified disorders of refraction

0.00

0.0

1.5

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.0

1.0

—

Congenital absence, atresia and stenosis of large intestine

0.00

0.0

1.0

—

Benign neoplasm: Aortic body and other paraganglia

0.00

0.0

1.2

—

Benign neoplasm: Cornea

0.00

0.0

1.2

—

Alzheimer’s disease (undefined)

0.00

0.0

1.0

—

Other helminthiases

0.00

0.0

1.3

—

Pure hyperglyceridaemia

0.98

0.00

1.2

1.1

—

Other mycoses, not elsewhere classified/unspecified

0.00

0.0

1.0

—

Rickettsioses

0.00

0.0

1.0

—

Hirsprung

0.00

0.0

1.0

—

Mandibular prognathia

1.00

0.00

1.8

1.3

—

Epidermolysis bullosa

0.00

0.0

1.0

—

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.00

0.0

1.3

—

Other congenital malformations of respiratory system

0.00

0.0

1.3

—

Diphtheria

0.00

0.0

1.2

—

Effects of other deprivation

0.00

-0.00

0.0

1.1

—

Other haemoglobinopathies

0.00

-0.00

0.0

1.0

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS